IBM Research will undertake research with Melanoma Institute Australia to help further advance the identification of melanoma using cognitive technology. This research builds on IBM’s existing research agreement with MoleMap, which uses advanced visual analytics to analyze more than 40,000 data sets including images and text. IBM Research plans to analyze dermatological images of skin […]
RESEARCH!AMERICA launched its Campaign for Cures 2016 election blog and an online interactive map featuring hundreds of quotes on medical progress from candidates across the political spectrum running for national office. Managed by former USA Today senior editor and health reporter Janice Lloyd, the blog features election news, survey data, commentary and analysis of presidential […]
THE AMERICAN CANCER SOCIETY plans to double its annual funding for research by 2021. The society made the announcement in conjunction with Vice President Biden’s National Cancer Moonshot Summit at Howard University in Washington, D.C. ACS plans to increase its annual research investment to approximately $240 million by 2021. The organization currently spends about $100 […]
JOEL KATZ was honored by City of Hope with the Spirit of Life Award. Katz, an entertainment attorney, is chair of the Global Entertainment and Media Practice of Greenberg Traurig, and was recognized for his work in the entertainment industry. Katz will be presented with the award at a gala in Los Angeles Nov. 10. […]
FIRAS ELADOUMIKDACHI was named program director for the Rutgers Cancer Institute of New Jersey at Hamilton. He will be responsible for clinical leadership of the oncology service line at RWJ Hamilton including medical, surgical and radiation oncology. Eladoumikdachi is an assistant professor of surgery at Rutgers Robert Wood Johnson Medical School. He has been with […]
STEPHEN BURLEY was named as co-program leader of the Cancer Pharmacology Research Program at Rutgers Cancer Institute of New Jersey. Burley will work with co-program leader X.F. Steven Zheng, a university professor at Rutgers Robert Wood Johnson Medical School, in determining the mode of action and mechanism of resistance to anti-cancer agents and developing novel […]
TYLER JACKS, SUSAN HOCKFIELD and PHILLIP SHARP, all of MIT, published a report on merging approaches from multiple scientific disciplines to produce breakthroughs in medical research. The report, “Convergence: The Future of Health,” was presented at the National Academies of Sciences, Engineering, and Medicine. Jacks is the David H. Koch Professor of Biology and director... […]
SHUANZENG “SAM” WEI and PHILIP PANCARI joined Fox Chase Cancer Center. Wei joined the department of pathology at Fox Chase Cancer Center as an assistant professor, where he will specialize in surgical pathology and cytopathology. Pancari joined the department of hematology/oncology at Fox Chase Cancer Center, providing additional physician support for the Fox Chase Cancer... […]
THE PROSTATE CANCER FOUNDATION named 24 Young Investigator Award winners. Members of the Class of 2016 were selected from a pool of 128 applicants from 77 institutions across 15 countries. Successful proposals included the use of genomics to predict prognosis and personalize treatments, as well as immunological approaches. The projects predominantly concentrated on treatment-resistant prostate... […]
THE NCI SURGERY BRANCH resumed enrollment of patients in clinical protocols evaluating immunotherapy as a treatment for patients with metastatic cancer.
